08/06/2025
5:02 AM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
5:05 AM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
4:16 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
4:05 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
3:46 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2025
4:14 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:21 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
4:06 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:08 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
4:09 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ONC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BeOne Medicines and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
3:25 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:08 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:09 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2025
4:12 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:49 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:51 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:38 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:39 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:42 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:44 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:45 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:15 PM | Ball Titus B. (Reporting)
BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
3:54 PM | BeOne Medicines Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:13 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
3:16 PM | BeOne Medicines Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
11:15 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:52 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POSASR | |
05/27/2025
3:26 PM | BeOne Medicines Ltd. (Filer)
BeOne Medicines (Filer)
| Form POS AM | |
05/27/2025
7:35 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K12G3 | |
05/26/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Riva Alessandro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:46 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
BRANDICOURT OLIVIER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:47 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:41 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
HOOPER ANTHONY C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:42 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
6:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Dugan Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:45 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:37 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). |
05/13/2025
4:53 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Capital International Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
5:09 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:09 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
7:26 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
4:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:21 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form ARS | |
04/07/2025
5:03 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEF 14A | |
04/07/2025
5:07 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
04/01/2025
3:27 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:53 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:51 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:43 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:51 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144/A | |
03/10/2025
3:19 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:08 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form DEFA14A | |
03/09/2025
11:15 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form EFFECT | |
03/10/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 424B3 | |
03/07/2025
7:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:26 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:20 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:22 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:24 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
4:22 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:48 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
8:31 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:30 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:49 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
8:43 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:40 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
8:28 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
02/28/2025
5:15 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form S-4/A | |
02/27/2025
5:04 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
5:12 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
3:23 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:24 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
5:12 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
3:29 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:44 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:02 PM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:08 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 10-K/A | |
01/07/2025
3:18 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). |
12/23/2024
5:05 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:02 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:18 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:25 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:30 PM | BAKER BROS. ADVISORS LP (Filed by)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form SC 13D/A | |
12/10/2024
7:19 PM | BeiGene, Ltd. (Issuer)
BeOne Medicines (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:26 PM | BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:02 AM | BeiGene, Ltd. (Filer)
BeOne Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:48 PM | 667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
BeOne Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
